SynteractHCR Expands Senior Leadership To Oversee Growth Of International Projects

SynteractHCR, a full-service, international contract research organization (CRO), has appointed three new senior-level managers to strengthen its leadership team internationally. The new hires include James Cappola, MD, PhD, as medical director, U.S., Gary Urban as director of quality assurance and Barbara Falk as safety surveillance manager, EMEA.

Free Webinar

From Patient Adherence to Manufacturing Ease - Why Softgels Make Sense for Rx

Join Thermo Fisher Scientific’s upcoming webinar to learn why softgels offer numerous benefits for Rx drug development, including enhanced bioavailability, patient compliance and easy scale-up. Register Today.

Suggested Articles

Polyphor is developing an inhaled version of murepavadin, which targets Pseudomonas aeruginosa infections, but is currently given intravenously.

Japanese pharma Astellas is looking to offload a series of unwanted research projects ahead of Thanksgiving; if you want one, it’s made it very easy.

A re-engineered adenovirus prolonged survival in mouse models of metastatic lung cancer and cleared tumors in about 35% of the animals.